The global lupus market represents a critical frontier in autoimmune disease management, characterized by evolving therapeutic approaches and increasing clinical understanding of systemic lupus erythematosus (SLE) and its various manifestations. With approximately five million people worldwide affected by lupus, pharmaceutical companies and research institutions are intensifying efforts...